Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jul 21, 2022
Reporting period
Not applicable
Filed with the SEC
Apr 22, 2026
CFOTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001800068-26-000003
Filed / recorded
Apr 22, 2026, 8:18 PM UTC
Added to OQRO
Oct 8, 2026, 2:27 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Sensus Healthcare, Inc.
Issuer CIK
1494891
Ticker
SRTS
Reporting person
Javier Rampolla
Relationship
Officer
Officer title
CHIEF FINANCIAL OFFICER
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Jul 21, 2022
Transaction code
F
Shares / units
3,935
Price per share
$10.51
Acquired / disposed
Disposed (D)
Shares owned after
48,114
Ownership form
Direct
Amendment
Yes (Form 4/A)
Footnotes from the filing
Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock.
On July 25, 2022, the reporting person filed a Form 4 (the "Original Report") which inadvertently reported that the reporting person owned 48,856 shares of the issuer's common stock as of July 21, 2022. In fact, the reporting person held 48,114 shares of the issuer's common stock as of July 21, 2022. As a result of the error in the Original Report, the number of shares of common stock beneficially owned by the reporting person as reported on each Form 4 filed by the reporting person between the date of the Original Report and the filing of this amendment to the Original Report was overstated by 742 shares.